Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mila S. Griffioen"'
Publikováno v:
Griffioen, M S, de Leeuw, D C, Janssen, J J W M & Smit, L 2022, ' Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies ', Cancers, vol. 14, no. 14, 3456 . https://doi.org/10.3390/cancers14143456
Venetoclax is a BCL-2 inhibitor that effectively improves clinical outcomes in newly diagnosed, relapsed and refractory acute myeloid leukemia (AML) patients, with complete response rates (with and without complete blood count recovery) ranging betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5469dbb9dc05ece7950f612302a682
https://doi.org/10.3390/cancers14143456
https://doi.org/10.3390/cancers14143456
Autor:
Griffioen, Mila S.1 (AUTHOR) m.s.griffioen@amsterdamumc.nl, de Leeuw, David C.1 (AUTHOR), Janssen, Jeroen J. W. M.1 (AUTHOR), Smit, Linda1 (AUTHOR) li.smit@amsterdamumc.nl
Publikováno v:
Cancers. Jul2022, Vol. 14 Issue 14, pN.PAG-N.PAG. 21p.